Ponds’ Insight into Skincare Routine Evolution

Industry & Competitive Context

The global skincare industry underwent a structural consumer transformation in the years following 2020. Driven by unprecedented access to dermatological content on digital platforms, a new category of consumer emerged — one that industry observers began calling the "Skintellectual." These consumers actively research ingredient lists, demand clinical substantiation for product claims, and approach skincare as a multi-step regimen rather than a single-product habit. The shift was consequential for mass-market legacy brands whose equity had been built on simplicity, familiarity, and broad appeal rather than scientific authority.

In India specifically, Hindustan Unilever Limited (HUL) — Pond's parent company — articulated this changing landscape explicitly in its FY2022–23 strategy communications, noting the evolution of consumer demand toward "premium beauty" and "science-backed products." HUL's own annual performance disclosures for FY23 confirmed that Pond's crossed the ₹2,000 crore turnover threshold that year, placing it in the company's elite tier of brands alongside LUX — a milestone that signalled both the brand's commercial scale and the strategic expectations riding on its next chapter. HUL's broader "Winning in Many Indias" (WiMI) strategy, as disclosed in the same performance document, had already directed the company to deaverage its portfolio by consumer skin type, climate, and geography — making a science-led skincare strategy a natural extension of parent-company intent.

Against this backdrop, competitors such as L'Oréal, Minimalist, Plum, and dermatologist-endorsed D2C brands were rapidly capturing the attention of ingredient-aware consumers. The competitive threat was not merely product-level but perceptual: newer entrants had successfully occupied the scientific credibility space that legacy brands had historically vacated in favour of mass-reach aspirational advertising.

Brand Situation Prior to the Rebranding

Pond's entered this competitive environment with one of the most storied legacies in global skincare. Founded in 1846 by pharmacist Theron T. Pond in Utica, New York, the brand had a history of genuine scientific firsts — it was among the earliest skincare brands to introduce dual-product routines (Cold Cream and Vanishing Cream), and by the 1920s had built a celebrity endorsement model involving royalty and socialites. Pond's became part of Unilever in 1987 and subsequently expanded to over 56 countries, becoming a household name across South and Southeast Asia.

However, the years leading up to 2023 had inflicted visible brand erosion. As Pond's own agency partner 1HQ Singapore and campaign agency Ogilvy Singapore publicly documented, the brand had undergone "several product re-positionings and pack relaunches since 2007" that had collectively damaged both premium perception and expert appeal. Despite retaining competent formulations, the brand's scientific credibility had suffered in the market. The brand, according to publicly disclosed campaign briefs, had been unable to keep pace with consumer movement toward "affluence, experience-rich offerings, and scientific innovations" — outcomes that led to documented declines in brand share and brand power.

In Mexico, a market where these dynamics were particularly visible, the brand's share had dropped from over 50% to 38%, as disclosed by Warc in its coverage of the brand's subsequent campaign results. The implication was structural, not cyclical: Pond's was no longer being perceived as a skincare science authority, but as a reliable, somewhat dated, mass-market moisturiser — a positioning that left it exposed to both premium skincare brands from above and aggressively priced D2C competitors from below.

Strategic Objective

The strategic goal Pond's set for itself was explicit and commercially bounded. As documented by The Drum in its coverage of the 2023 relaunch, the packaging and brand refresh was initiated with "the business ambition of becoming a $1 billion brand by 2026." The strategic objective, therefore, was not incremental brand refresh but substantive repositioning: moving the brand from its historic identity as a mass-brightening product to what the brand publicly described as a "masstige" skincare brand — a positioning that would allow it to command higher price points, attract the Skintellectual consumer segment, and compete in premium-adjacent skincare without abandoning its mass-market distribution base.

This required a simultaneous intervention on three dimensions: brand identity, product formulation, and communication strategy. A brand that had allowed its scientific heritage to atrophy needed to reclaim expert positioning through concrete, credentialed innovation — not merely through packaging changes or aspirational advertising.

Campaign Architecture & Execution

The vehicle chosen to execute this repositioning was the reintroduction and elevation of "Pond's Skin Institute" as an institutional identity — a name that had historically existed but was now being reasserted as the brand's primary public face, signalling a transition from consumer brand to credentialed skincare authority.

The relaunch began in October 2023 in Indonesia and was designed to cascade through Southeast Asia and the rest of the world into 2024. In India, Pond's Skin Institute held a formal launch event in Mumbai, attended by senior HUL leadership, celebrity brand ambassadors, and a practising dermatologist — a deliberate staging choice that underscored the brand's claim to scientific legitimacy.

The campaign's creative platform, developed with Ogilvy Singapore, was titled "Miracles Happen." The tagline was built around a specific consumer insight that Ogilvy's Global Managing Partner Aanchal Sethi publicly articulated: that despite sustained effort, nine out of ten women struggle to close the gap between their current skin and their desired skin, and that the barrier to achieving this outcome feels almost miraculous. The campaign positioned Pond's Skin Institute's scientific innovations as the mechanism capable of making that miracle scientifically achievable.

The product range launched under this campaign — the Bright Miracle range — incorporated two proprietary trademarked ingredients: Niasorcinol™ and Hexyl-Retinol™, developed after more than 15 years of research within Unilever's laboratories. Critically, these ingredients were not simply described in consumer advertising; they were first presented at the World Congress of Dermatology in 2023 and received endorsements from dermatologists and medical professionals, as documented on Unilever's official brand pages. This upstream scientific credentialing — presenting ingredients to a professional medical audience before consumer launch — was a deliberate strategic choice that distinguished Pond's Skin Institute's launch from conventional FMCG product introductions.

The brand also incorporated Nobel Prize-winning autophagy science into the Bright Miracle formulation — as publicly disclosed in Ogilvy's campaign descriptions — referencing the mechanism by which cells self-repair, and positioning it as a skin regeneration technology.

Global ambassador selection reinforced the brand's strategic intent. K-pop star Tzuyu from Twice was onboarded as the global ambassador for Southeast Asia, aligning the brand with a cultural currency that commanded credibility and aspiration among the Skintellectual demographic. For India specifically, Kiara Advani and Keerthy Suresh were announced as brand ambassadors in June 2024, as documented by indiantelevision.com, with campaign TVCs designed to communicate the elevated, premium avatar of the brand. By 2026, the brand further elevated its global ambassador strategy by appointing Thai actor Urassaya "Yaya" Sperbund — who had maintained a decade-long relationship with Pond's in Thailand — to a global ambassador role.

The visual identity overhaul was executed by 1HQ Singapore, which drew on the brand's three most recognisable historical assets — the iconic pink colour, the tulip logo, and the notion of "skincare science" — and recombined them through a contemporary lens focused on ingredient-led storytelling. New packaging prominently featured the trademarked ingredient names as visual focal points, communicating scientific specificity where earlier packaging had featured aspirational imagery.

Positioning & Consumer Insight

The strategic insight that animated the entire repositioning was a fundamental tension in the modern skincare consumer's experience: she is more knowledgeable about skincare than any previous generation, yet simultaneously more dissatisfied — because her heightened awareness of what is possible has raised her expectations beyond what most products historically delivered. She has absorbed the language of active ingredients, layering protocols, and routine sequencing from dermatologist creators and skincare communities. She now approaches her bathroom shelf as a curated, multi-step routine rather than a single product application.

The "9 out of 10 women struggle to bridge the gap" insight, as publicly quoted by Ogilvy's Aanchal Sethi in Campaign Asia, crystallised this tension. The insight did not position the problem as ignorance (as older skincare advertising might have) but as a gap between informed desire and achievable outcome — a gap that science, not inspiration, could close.

This is a strategically significant shift in the brand's orientation. Pond's historic communications had often been aspirational and cosmetic — focused on how skin looked after using the product. The Skin Institute repositioning moved the brand's promise from cosmetic aspiration to scientific efficacy, from emotional desire to clinically verifiable outcome. The introduction of a 3-step regimen structure — Facewash, Serum, Serum Cream, as documented across Unilever's Bangladesh and other market pages — was itself a product architecture decision rooted in the consumer insight that modern skincare consumers do not want a single product; they want a routine system that they can understand and execute.

The Pond's Skin Institute name itself performed positioning work that no amount of advertising copy could replace. "Institute" carries connotations of research, credentialing, and clinical seriousness that the word "Pond's" alone — however trusted — could not project into the Skintellectual segment.

Media & Channel Strategy

Based on publicly available information, the media and channel strategy operated across three primary layers. First, the brand executed high-profile launch events in key markets — Mumbai in India, and equivalent activations in Southeast Asia — designed to generate earned media coverage and signal the brand's premium intent to trade partners and the press simultaneously.

Second, the campaign deployed a social-first content architecture, with Ogilvy developing what the agency publicly described as "captivating videos, inspiring social media content, and arresting in-store designs." The use of Tzuyu as a global ambassador specifically addressed the digital and social media ecosystem in Southeast Asia, where K-pop cultural currency commands organic amplification and influencer ecosystem participation.

Third, the brand executed influencer partnerships focused on educational skincare content, leveraging the existing Skintellectual creator ecosystem rather than traditional broadcast formats. This content approach aligned the brand with the consumer's own information-seeking behaviour — on social platforms, in ingredient deep-dive videos — rather than interrupting it.

In India, the brand deployed TVCs featuring Kiara Advani and Keerthy Suresh, maintaining above-the-line broadcast presence to protect mass-market reach while the premium repositioning played out in digital channels. No verified public information is available on specific media spend breakdowns, programmatic strategy, or paid media allocation ratios across these channels.

Business & Brand Outcomes

The documented business and brand results are drawn entirely from verified public sources. In Mexico, where the Warc case study provided specific market data, Pond's achieved a 1.42% increase in market share within the first six months of the "Miracles Happen" campaign and doubled its sales growth rate compared to the prior year period — both figures as reported by Warc. This outcome was particularly significant given that the brand's market share in Mexico had declined from over 50% to 38% in the period preceding the relaunch, making the recovery directionally meaningful even if the absolute share recovery remained a work in progress.

In India, Hindustan Unilever's FY23 performance highlights — as published on HUL's official performance disclosure platform — confirmed that both LUX and Pond's crossed ₹2,000 crore in turnover that year, making Pond's one of five Beauty and Personal Care brands at that scale in HUL's India portfolio. The same disclosure noted "double-digit competitive growth, broad-based across the portfolio," though brand-specific growth attributions for Pond's were not individually disaggregated in public filings.

The brand's stated ambition of becoming a $1 billion global brand by 2026, as publicly documented by The Drum and multiple trade publications, provides an externally disclosed financial target against which the strategy's long-term effectiveness will be assessed. No verified public information is available on whether that target has been achieved as of the case study's writing.

Strategic Implications

The Pond's Skin Institute repositioning offers several analytically significant implications for brand strategy in the FMCG context.

The first and most important is the strategic utility of scientific credentialing as a positioning lever for legacy brands. Pond's did not invent new science for the purpose of this campaign — the Niasorcinol™ and Hexyl-Retinol™ technologies had been in development for over 15 years within Unilever's R&D infrastructure. What changed was the decision to make that science visible, nameable, and institutionally credentialed before consumer launch. Presenting these ingredients at the World Congress of Dermatology before advertising them to consumers reversed the traditional FMCG sequence of product launch, and in doing so, built a form of credibility that consumer advertising alone cannot manufacture.

The second implication concerns the relationship between brand architecture and positioning intent. The decision to rename the brand Pond's Skin Institute — rather than simply relaunching Pond's under a new campaign — reflects an understanding that nomenclature itself carries positioning weight. Brand names are not neutral containers; they activate associations. "Institute" signals permanence, research, and authority. The name change was doing strategic work that creative execution could not accomplish on its own.

The third implication is about the evolving role of the consumer routine as a unit of competitive strategy. Pond's Skin Institute did not simply launch new products; it launched a product system — facewash, serum, cream — designed to map onto the multi-step skincare routine that Skintellectual consumers had already internalised. This is a category-architecture insight: the competitive arena has shifted from individual product performance to routine ownership. The brand that owns the consumer's entire routine sequence commands higher lifetime value, deeper behavioural lock-in, and greater basket size than the brand that captures only a single step.

The fourth implication is about the cultural specificity of scientific aspiration. The selection of Tzuyu as a global ambassador in Southeast Asia and Kiara Advani in India reflects a market-specific understanding of whose scientific credibility consumers find aspirational. The Skin Institute positioning was not communicated abstractly; it was rooted in local cultural codes about beauty, achievement, and expertise. Scientific authority alone is insufficient — it must be mediated through cultural figures whose relationship with beauty carries authenticity in the specific market context.

Finally, the Pond's case illustrates the compounding risk of neglecting brand positioning during periods of commercial stability. The brand's share erosion — particularly in markets like Mexico — occurred not through a single strategic failure but through a gradual drift away from the scientific authority that had originally differentiated the brand. Brands that allow equity to erode passively while managing short-term volume through pricing and distribution face a more expensive repositioning problem later. The cost of reclaiming scientific credibility is substantially higher than the cost of maintaining it.

Discussion Questions

1. Pond's chose to relaunch its scientific credentials by presenting proprietary ingredients at the World Congress of Dermatology before consumer advertising. What are the strategic risks of this upstream credentialing approach, and under what conditions might a competing brand successfully counter it without access to equivalent R&D infrastructure?

2. The "Skintellectual" consumer segment is characterised by high information literacy and resistance to aspirational advertising. How should Pond's Skin Institute calibrate the balance between scientific communication and emotional brand storytelling to retain this segment without alienating its mass-market base?

3. Pond's positioned its 3-step regimen system as a core product architecture. Analyse the competitive implications of routine ownership as a strategic objective. How does this shift change the metrics by which success should be evaluated at the brand level?

4. The brand simultaneously operates in the mass market (retaining broad distribution and price accessibility) and seeks premiumisation (masstige positioning, clinical credentials). Is this positioning sustainable over a five-year horizon, or does the pursuit of premium equity inevitably erode mass-market relevance? Use HUL's portfolio strategy as evidence in your analysis.

5. The documented market share recovery in Mexico (1.42% in six months) and the doubling of sales growth rate are the most specific publicly disclosed outcomes from this campaign. What additional metrics would you require to make a comprehensive judgment on the long-term effectiveness of the Pond's Skin Institute repositioning, and how would you design a measurement framework to capture them?